Woebot

Built by Stanford psychologists, Woebot is an AI chatbot that delivers cognitive behavioral therapy techniques through conversation. A randomized controlled trial published in JMIR Mental Health showed it significantly reduced depression symptoms in just two weeks. Unlike generic chatbots, Woebot's responses are rooted in evidence-based CBT, DBT, and interpersonal psychotherapy frameworks. It's free, available 24/7, and doesn't judge you for texting at 3 AM. The FDA granted it Breakthrough Device designation in 2023.